首页> 美国卫生研究院文献>Current Controlled Trials in Cardiovascular Medicine >Metacognitive therapy vs. eye movement desensitization and reprocessing for posttraumatic stress disorder: study protocol for a randomized superiority trial
【2h】

Metacognitive therapy vs. eye movement desensitization and reprocessing for posttraumatic stress disorder: study protocol for a randomized superiority trial

机译:元认知疗法与创伤后应激障碍的眼球运动脱敏和再处理:一项针对随机优势试验的研究方案

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundThe psychological treatment of choice for patients with severe posttraumatic stress disorder (PTSD) is cognitive behavioural exposure therapy or Eye Movement Desensitisation Reprocessing (EMDR). Whilst these are the most effective treatments, approximately 30–45% of the patients show no significant improvements and follow-up data are sparse. Furthermore, a proportion of patients with severe trauma does not benefit or avoid exposure therapy due to the potential to overwhelm them. Therefore, it is necessary to search for effective methods that do not require exposure. Metacognitive therapy (MCT), a recent treatment approach to PTSD that does not require exposure, has potential strong treatment effects but so far a comparison with EMDR has not been made.
机译:背景技术重度创伤后应激障碍(PTSD)患者的心理治疗选择是认知行为暴露疗法或眼动脱敏再加工(EMDR)。尽管这些是最有效的治疗方法,但约30–45%的患者没有明显改善,随访数据稀疏。此外,由于可能使他们不堪重负,有一部分严重创伤的患者没有受益或避免接触治疗。因此,有必要寻找不需要暴露的有效方法。元认知疗法(MCT)是不需要暴露的PTSD的最新治疗方法,具有潜在的强大治疗效果,但到目前为止,尚未与EMDR进行比较。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号